Remarkably, these two proteins co-localize by immunohistochemistry in PDA tissue sections, suggesting that Gal3–LI-cadherin binding plays a role in pancreatic cancer [82]. This evidence concerns the gene LGALS3 and Patent ductus arteriosus.